Quantcast

Latest Microbicide Stories

2012-07-09 23:00:14

The National Science Foundation awards a $150,000 Phase I SBIR Grant to Agile Sciences Raleigh, NC (PRWEB) July 09, 2012 Agile Sciences has been awarded $150,000 for a NSF Phase I SBIR project entitled “Enhancing the Bactericidal Activity of Copper: An Economically Viable Solution for Lowering Copper Usage Rates in Agriculture.” Agile Sciences will collaborate with North Carolina State University Professor of Plant Pathology, Dr. David Ritchie, to evaluate Agile Sciences´...

2012-04-17 10:22:33

A newly launched African-inspired, African-led initiative says 'yes' to rectal microbicides Today IRMA (International Rectal Microbicide Advocates) will release "On the Map: Ensuring Africa's Place in Rectal Microbicide Research and Advocacy" at a special evening reception at the international Microbicides 2012 conference at the Sydney Convention and Exhibition Center. A cornerstone of IRMA's Project ARM (Africa for Rectal Microbicides) initiative, the strategy document developed by...

2011-03-07 14:16:18

Microbicides can be used to protect against HIV, and other sexually transmitted diseases, either on their own or with the added protection of a condom. New research published by BioMed Central's open access journal AIDS Research and Therapy has investigated the use of lubricants, originally designed for vaginal application, and has developed and tested new, rectal specific, formulations. Unprotected sex is one of the major ways that HIV spreads through the population. However most research...

2010-01-26 12:00:00

BETHLEHEM, Pa., Jan. 26 /PRNewswire/ -- Particle Sciences, a leading drug development CRO, will share formulation, analytic and production responsibilities in an effort to develop a vaginally administered microbicide, a product specifically designed to prevent the sexual transmission of HIV. According to Robert Lee, VP Pharmaceutical Development at Particle Sciences, "Particle Sciences is well qualified for this challenge having extensive expertise in mucosal formulation and previous...

2009-05-28 11:19:31

New research in the FASEB Journal describes a one-two punch in the battle against HIV In what could be a major pharmaceutical breakthrough, research published online in The FASEB Journal (http://www.fasebj.org) describes how scientists from St George's, University of London have devised a one-two punch to stop HIV. First the report describes a new protein that can kill the virus when used as a microbicide. Then the report shows how it might be possible to manufacture this protein in...

2008-08-22 09:01:11

LEXINGTON, Mass., Aug. 22 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. announced today the completion of enrollment in Protocol MDP 301, a Phase III clinical trial of PRO 2000, the Company's candidate vaginal microbicide for the prevention of HIV and other sexually transmitted infections. The trial is sponsored by the United Kingdom's Medical Research Council (MRC) and conducted by the Microbicides Development Programme (MDP), an international partnership of researchers...

2008-07-29 09:01:15

FREDERICK, Md., July 29 /PRNewswire/ -- ImQuest BioSciences announced today the successful acquisition of funding from the National Institute of Allergy and Infectious Disease (NIAID/NIH) to support the development of pyrimidinedione inhibitors as topical microbicides to prevent the sexual transmission of HIV. The two year Small Business Innovative Research (SBIR) grant provides funding for the continued development of the dual-acting pyrimidinedione molecules which effectively inhibit two...

343d871ec7fd4dce554c9b2d572078e0
2008-07-08 13:37:12

Gels that have been developed to protect women from the AIDS virus may be just as likely to protect men from catching the disease as well, researchers said on Monday. That prediction would rely on the event of such gels and creams being perfected to be effective for men. Sally Blower of the University of California, Los Angeles, and David Wilson of the University of New South Wales in Sydney, Australia said women who use gels of microbicides could end up with fewer treatment options if they...

2005-11-01 12:50:00

Experiments in female monkeys have for the first time shown that when used in combination, vaginal gels known as microbicides can protect against an HIV-like virus. The research, funded largely by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), suggests that similar combination microbicides could potentially provide a safe, effective and practical way to prevent HIV transmission to women, according to study investigators. The...

2005-10-31 13:31:05

Research with female monkeys at the Tulane National Primate Research Center has for the first time shown that three different anti-viral agents in a vaginal gel protect the animals against an HIV-like virus. The research suggests that a microbicide using compounds that inhibit the processes by which HIV attaches to and enters target cells could potentially provide a safe, effective and practical way to prevent HIV transmission in women, according to study investigators. The study, published...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.